Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:57 PM
Ignite Modification Date: 2025-12-25 @ 3:20 PM
NCT ID: NCT02227368
Description: Only SAEs and AEs of interest were collected for this study. Treatment Emergent SAEs and Treatment Emergent AEs of interest are reported here.
Frequency Threshold: 0
Time Frame: 26 weeks treatment period + 30 days followup
Study: NCT02227368
Study Brief: Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ticagrelor Ticagrelor 90mg twice a day plus aspirin placebo once daily None None 4 16 1 16 View
Aspirin Aspirin 100mg once daily plus ticagrelor placebo twice a day None None 2 24 1 24 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Coronary artery disease SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA Version 17.0 View
Cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 17.0 View
Osteomyelitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 17.0 View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 17.0 View
Skin ulcer SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Version 17.0 View
Haemorrhage SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA Version 17.0 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA Version 17.0 View
Peripheral artery stenosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA Version 17.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Procedural haemorrhage SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA Version 17.0 View
Arterial occlusive disease SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA Version 17.0 View